相关实验视频

Updated: Jan 16, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

miR-221-3p通过向脂肪细胞中的SOCS1来加剧肥胖引起的胰岛素抵抗

Nan Li^1,2, Liang Zhang³, Qiaofeng Guo²

¹Center for Physical Education, Xi'an Jiaotong University, Xi'an 710049, China.

|September 26, 2025

概括

脂肪组织中微RNA-221-3p (miR-221-3p) 的上调会使胰岛素耐药性恶化. 抑制miR-221-3p通过向SOCS1来改善胰岛素敏感性,为代谢障碍提供了一种新的治疗策略.

科学领域:

代谢研究的研究.
分子生物学分子生物学
内分泌学在内分泌学.

背景情况:

胰岛素抵抗 (IR) 是2型糖尿病和心血管疾病的关键因素.
微RNAs (miRNAs) 涉及各种生物过程,但它们在IR病原发生中的作用尚不清楚.
了解IR的miRNA调节对于开发新的治疗策略至关重要.

研究的目的:

研究特定miRNAs在调节胰岛素抵抗中的作用.
阐明miRNAs影响代谢变化的分子机制.
为了确定潜在的基于miRNA的治疗点对IR.

主要方法:

已建立的高脂肪饮食 (HFD) 诱导的IR小鼠模型和棕酸盐处理的3T3-L1细胞.
从HFD小鼠的脂肪组织 (AT) 中分析了miRNA表达特征.
利用双 luciferase 记者测定来确认 miR-221-3p 直接针对 SOCS1.
通过实时PCR和西式涂抹来评估代谢变化.

主要成果:

在HFD诱导的IR模型的AT中,miR-221-3p表达显著升高.
调节miR-221-3p加剧的葡萄糖平衡乱和胰岛素抵抗.
抑制miR-221-3p增强了胰岛素敏感性,减少了脂质积累,并使葡萄糖代谢正常化.
miR-221-3p直接针对SOCS1的3'-UTR,调节PI3K/AKT通路.

结论:

脂肪组织中的miR-221-3p/SOCS1轴在调节葡萄糖代谢方面发挥着至关重要的作用.
准miR-221-3p/SOCS1通路为治疗胰岛素抵抗和糖尿病提供了一种新的治疗方法.

关键词:

通过PI3K/AKT路径.葡萄糖的新陈代谢.这是一个小RNARNA.肥胖肥胖肥胖肥胖肥胖肥胖肥胖肥胖

更多相关视频

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

相关概念视频

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

Insulin: The Receptor and Signaling Pathways

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...